Topotecan research moves forward at last.
Smart
T
T
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D002166:Camptothecin / Q000009:adverse effects / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D016325:HIV Long Terminal Repeat; D015497:HIV-1 / Q000187:drug effects / Q000235:genetics / Q000502:physiology; D006801:Humans; D007968:Leukoencephalopathy, Progressive Multifocal / Q000188:drug therapy; D008223:Lymphoma / Q000188:drug therapy; D009154:Mutation; D012514:Sarcoma, Kaposi / Q000188:drug therapy; D059004:Topoisomerase I Inhibitors; D019772:Topotecan; D014779:Virus Replication / Q000187:drug effects
D000970:Antineoplastic Agents; D000998:Antiviral Agents; D059004:Topoisomerase I Inhibitors; D019772:Topotecan; D002166:Camptothecin